|会社名||Canopy Growth Corp （キャノピ―・グロ―ス）|
|業種||― 医療関連（Health Care）|
|概要||― キャノピ―・グロ―スはカナダの医療用大麻製造会社。乾燥、オイル、ソフトジェルタイプなど、主に医療用大麻の製造を手掛ける。また、産業用ヘンプの栽培を行い、食品、化粧品、繊維、工業用製品や、医療用のCBD(カンナビジオ―ル)などの原料を供給する。製品は国内向けのほか、大麻が合法化されている国へ販売する。本社所在地はオンタリオ州スミスフォ―ルズ。 Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation,the Company offers product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Its global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through its award-winning Tweed and Tokyo Smoke banners, the Company reach its adult-use consumers and hasbuilt a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional federally-permissible CBD products to the United States through its First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.|
|本社所在地||1 Hershey Drive Smiths Falls Ontario K7A 0A8 CAN|
Canopy Growth Corp. (CGC) CEO David Klein on Q1 2022 Results - Earnings Call Transcript 2021/08/06 20:52:07 Seeking Alpha
''Not where we want to be:'' Smiths Falls'' Canopy Growth market share softened in Q1 2021/08/06 18:29:00 CityNews Ottawa
"It all comes back to execution," Chief Financial Officer Mike Lee said. "That is the largest driver behind our share loss in Canada."
Marijuana firm Canopy Growth posts CA$136M in net revenue for fiscal Q1 2021/08/06 16:27:27 Marijuana Business Daily
Canadian marijuana producer Canopy Growth Corp. reported net revenue of 136.2 million Canadian dollars ($108.4 million) for the first quarter of its 2022 fiscal year, an 8.2% decline from the CA$148.4 million reported in the fourth quarter 2021. However, the latest quarterly net revenue total is up 23.4% growth versus the same quarter last year.  Marijuana firm Canopy Growth posts CA$136M in net revenue for fiscal Q1 is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Insider Cannabis: Top psychedelic startups New York legalization woes Earnings, earnings, earnings 2021/08/06 16:27:02 Business Insider
Summary List Placement Welcome to Insider Cannabis, our weekly newsletter where we''re bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom. Sign up here to get it in your inbox every week . Hello everyone, Can''t believe it''s already August. We''re busy prepping for a whirlwind week of earnings we''ve got Curaleaf , Green Thumb Industries , and Trulieve , among many other multistate operators reporting. We''ve also lined up a few interviews with execs, so get in touch if there are questions you''d like us to ask. What else? Yeji has a look at the hottest psychedelic startups this year. It could take years for pot shops to open in New York 2023 is one Wall Street analyst''s optimistic guess. I went on the WVON Morning Show today to discuss the issues facing social equity licenses in the cannabis industry, the big money lobbying for legalization, and more. If you had a chance to listen, let me know what you think. Let''s get to it. - Jeremy Berke ( @jfberke ) & Yeji Jesse Lee ( @jesse_yeji ) If you like what you read, share this newsletter with your colleagues, friends, boss, spouse, strangers on the internet, or whomever else would like a weekly dose of cannabis news.
Hemp-Based Food Market 2021 Global Size, Share, Demand, Future Growth, Global Survey, In-depth Analysis, Key Findings | Agropro, Nutiva, Compass Group Management LLC, Canopy Growth, Hempco Inc 2021/06/28 17:58:48 OpenPR
Latest launched research document on Hemp-Based Food Market study of 350 Pages provides detailed analysis with presentable graphs, charts and tables. This report covers a detailed study of the Hemp-Based Food Market size, growth, and share, trends, consumption, segments, application
Costa Group auction clears at $3.30 2021/06/27 02:52:41 The Australian Financial Review
The beefed up fruit and vegetable grower Costa Group is worth $3.30 a share following its $200 million acquisition of Presslers 2PH Farms Pty Ltd, according to institutional investors that bid for Costa stock into a UBS-run auction.
Canopy Growth Closes Acquisition of Supreme Cannabis 2021/06/24 14:00:56 Smarter Analyst
Canopy Growth (WEED), one of the worlds largest cannabis companies, announced on Wednesday that it has completed the acquisition of The Supreme Cannabis The post Canopy Growth Closes Acquisition of Supreme Cannabis appeared first on Smarter Analyst .
Citrus Blossoms For Costa Group 2021/06/24 02:29:17 FNArena
The expansion of citrus orchards continues apace for Costa Group, with the latest acquisition adding scale and significant export opportunities The post Citrus Blossoms For Costa Group appeared first on FNArena .
Cannabis Mergers: Canopy Growth Issues 9 Million Shares To Complete Acquisition Of Supreme Cannabis Co. 2021/06/23 18:01:28 Benzinga
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC ) has merged with The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF ), wrapping up their previously announced deal on Tuesday. Transaction Details: Canopy acquired all of the issued and outstanding common shares of Supreme, which became a wholly-owned subsidiary of Canopy. In return, Supreme shareholders will receive 0.01165872 of a common share of Canopy and $0.0001 in cash for each Supreme share held. Under the terms of the agreement, Canopy issued roughly 9,013,400 shares and paid around $84,096.89 in cash in exchange for Supreme shares. To obtain shares of Canopy, shareholders of Full story available on Benzinga.com
Houseplant, Seth Rogen And Evan Goldberg's Cannabis Brand, To Debut In The US 2021/03/01 22:02:29 Benzinga
Houseplant , Seth Rogen and Evan Goldberg’s cannabis and lifestyle brand, is launching in the U.S. on March 11. The brand was founded in Canada back in April 2019 in partnership with cannabis giant Canopy Growth Corp. (NYSE: CGC ). Since then, it has become one of the most coveted celebrity-backed brands in the cannabis industry. In an email to Benzinga, Houseplant explained that, even though Canopy will continue to be its licensee in Canada, it is not involved in the U.S. launch. “We are thrilled to launch in the US, bringing cannabis products to our fellow Californians and an original line of Housegoods to consumers nationwide," Houseplant co-founder and CEO Michael Mohr told Benzinga. "It is only … Full story available on Benzinga.com
Cannabidiol (CBD) Market to See Booming Growth | Elixinol, Aphria, Canopy Growth, NuLeaf Naturals 2021/02/27 09:00:07 OpenPR
Stay up-to-date and exploit latest trends of Cannabidiol (CBD) Market with latest edition released by AMA. Cannabidiol (CBD) Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Cannabidiol (CBD) industry with an
Canopy Growth's Chief Product Officer On How COVID-19 Accelerated Cannabis Demand 2021/02/26 21:32:50 Benzinga
The COVID-19 pandemic accelerated demand for tools to cope with stress management and anxiety, Canopy Growth Corp (NASDAQ: CGC ) President and Chief Product Officer Rade Kovacevic said Friday during Benzinga's Cannabis Capital Conference . Cannabis And Stress Management: It goes without saying that rising anxiety is a trend that was seen worldwide, and this created new opportunities for both the cannabis industry as a whole and Canopy Growth , Kovacevic said during the virtual Benzinga conference. He called Canopy's Storz & Bickel the "gold standard" for luxury cannabis goods and said the brand benefited from consumers demanding the best product to help cope with never-ending Zoom meetings and life at home. The CBD space is perhaps best known for its stress management characteristics, so sales were naturally higher throughout 2020, … Full story available on Benzinga.com
Item 9 Labs and Why Franchising is the Growth Vehicle to Propel the Cannabis Industry 2021/02/26 15:06:38 Benzinga
Item 9 Labs Corp. is a sponsor and will speak at the Benzinga Cannabis Capital Conference set to take place on February 25-26, 2021. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. The cannabis industry is having a prime moment and a promising horizon ahead. After a transformative 2020, the market is experiencing policy changes worldwide, rising cannabis stocks and a high demand that positions the industry for exponential growth in the coming years. Additionally, Mergers and Acquisitions ( M&A) activity is expected to increase as cannabis stock valuations are becoming more realistic. In fact, many M&As are taking place all over the industry, reinforcing this trend. For example, Jazz Pharmaceuticals (NASDAQ: JAZZ ) has inked a deal to acquire GW Pharmaceuticals (NASDAQ: GWPH ), Cresco Labs (OTC: CRLBF ) acquired Origin House , and Canopy Growth Corp. (NASDAQ: CGC ) and Acreage Holdings (OTC: ACRHF ) are en route to merge.
The world's largest cannabis companies are jockeying to dominate the lucrative US market. 7 top CEOs and executives break down the deals you can expect. 2021/02/25 14:23:10 Business Insider
Summary List Placement The US cannabis industry is set for a flurry of deals as Democrats on Capitol Hill make cannabis reform a core issue and new state markets open. Insider spoke with top executives at seven of the largest cannabis companies. They said that they'll be focused on expanding their footprints as new state markets open up. They also said they'd use deals to scoop up valuable intellectual property as they jockey for control of the lucrative US market. And there is another battle looming: Canadian companies like Canopy Growth, Aurora, Tilray, and Aphria, are all preparing to enter the US market as soon as they can, encroaching on US firms like Green Thumb Industries and Curaleaf. "These businesses, ours included, are going to become very big and very well-capitalized." Ben Kovler, the CEO of US cannabis company Green Thumb Industries (GTI) told Insider. In the US, cannabis is legal in 15 states for recreational purposes and in 36 states for medical use. Cowen analyst Vivien Azer has projected that the legal US cannabis industry could balloon to a $100 billion market by 2030, and companies are working hard to ensure that they'll win a slice of that.
関連キーワード （― 米国株 キャノピ―・グロ―ス CGC ）